Non‐steroidal mineralocorticoid receptor antagonist vs selective aldosterone antagonist
Death · proteinuric chronic kidney disease
Non‐steroidal mineralocorticoid receptor antagonist showed no clear difference in death compared with selective aldosterone antagonist (low certainty).
1 finding from 1 review
- Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic… 2020 · Cochrane Headline outcomes onlyRR 0.7 [0.31, 1.55]1 study · 1055 participantsLow